SCHEMBL5676741

SCHEMBL5676741

CCc1ccc(O)c(O)c1C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCI P41743 1/20 0.46
SELL P14151 1/20 0.43
SELP P16109 1/20 0.43
PTPN11 Q06124 2/20 0.42
PTPN1 P18031 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
GABRA1 P14867 1/20 0.41
GABRB2 P47870 1/20 0.41
BID P55957 3/20 0.41
MCL1 Q07820 3/20 0.41
BCL2L1 Q07817 2/20 0.41
BAK1 Q16611 2/20 0.41
KAT8 Q9H7Z6 2/20 0.41
PPARG P37231 1/20 0.41
PPARA Q07869 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14390687 0.87 GABRA1 (0.50) PRKCIPTPN11PTPN1CA12CA1
SCHEMBL5192967 0.86 PRKCI (0.59) PRKCIPTPN11PTPN1BIDMCL1
SCHEMBL9328639 0.85 SELL (0.45) PRKCISELLSELPPTPN11PTPN1
SCHEMBL5194899 0.83 BID (0.58) PRKCIBIDMCL1BCL2L1BAK1
SCHEMBL5788356 0.83 PRKCI (0.55) PRKCISELLSELPPTPN11PTPN1
SCHEMBL5675080 0.82 BID (0.65) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL5588763 0.82 SELL (0.42) PRKCISELLSELPPTPN11CA12
SCHEMBL7824485 0.82 DUSP3 (0.61) PRKCISELLSELPPTPN11CA12
SCHEMBL5589276 0.82 MCL1 (0.44) PRKCISELLSELPPTPN11CA12
SCHEMBL5587907 0.82 SELL (0.42) PRKCISELLSELPPTPN11CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104321434-A Methods for biosynthesizing 1,3butadiene INVISTA TECH SARL 2015-01-28 CN claimed
CN-116731798-A Fluorine-free cleaning agent, and preparation method and application thereof 嘉庚创新实验室 2023-09-12 CN disclosed
CN-114317127-B Fluorine-free cleaning agent, and preparation method and application thereof 嘉庚创新实验室 2023-07-04 CN disclosed
CN-104769119-A Methods for biosynthesizing 1,3 butadiene INVISTA TECH SARL 2015-07-08 CN disclosed
CN-104321434-A Methods for biosynthesizing 1,3butadiene INVISTA TECH SARL 2015-01-28 CN disclosed
US-20060036049-A1 Soluble late transition metal catalysts for olefin oligomerizations III ZHAO BAIYI 2006-02-16 US disclosed
EP-1620447-A1 SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III Exxonmobil Chemical Patents Inc. (US) 2006-02-01 EP disclosed
WO-2003102006-A1 SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III EXXONMOBIL CHEMICAL PATENTS INC. (US) 2003-12-11 WO disclosed
CN-1268161-A Cleaning composition containing specific oxygenase PROCTER & GAMBLE (US) 2000-09-27 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060036049-A1 Soluble late transition metal catalysts for olefin oligomerizations III COMT, CD69, SPR PRKCI 4096/4885SELL 1902/4885SELP 1617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.